CSL's Se­qirus caps off $156M ex­pan­sion of flu man­u­fac­tur­ing fa­cil­i­ty in Raleigh sub­urb

The flu vac­cine man­u­fac­tur­er Se­qirus has com­plet­ed a new fa­cil­i­ty ex­pan­sion at its site in Hol­ly Springs, NC, a sub­urb of Raleigh.

The ex­pan­sion, which start­ed in 2018, cost the com­pa­ny $156 mil­lion and will add around 80 jobs to the area. The ex­pan­sion will al­so bring the Hol­ly Springs site to a to­tal of 664,000 square feet, ac­cord­ing to the com­pa­ny.

The ex­pan­sion is de­signed to sup­port the for­mu­la­tion and fill-fin­ish of its cell-based flu vac­cines in pre-filled sy­ringes for glob­al dis­tri­b­u­tion. The com­pa­ny cur­rent­ly man­u­fac­tures three types of flu vac­cine in­clud­ing Afluria, Flu­ad and Flucel­vax.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER